T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.36%356.831.2%$818.26m
AMGNAmgen Inc.
-1.01%189.831.2%$543.35m
CELGCelgene Corporation
-0.36%85.031.2%$517.56m
GILDGilead Sciences, Inc.
-0.07%77.000.9%$473.15m
VRTXVertex Pharmaceuticals Incorporated
-1.16%178.031.9%$311.89m
REGNRegeneron Pharmaceuticals, Inc.
-0.36%366.412.6%$283.41m
ILMNIllumina, Inc.
0.44%310.463.5%$265.60m
SRPTSarepta Therapeutics, Inc.
-0.45%134.9216.6%$231.08m
BLUEBluebird Bio, Inc.
0.96%180.6815.7%$203.89m
ALXNAlexion Pharmaceuticals, Inc.
-0.02%135.072.0%$176.52m
NKTRNektar Therapeutics
-1.41%48.395.6%$171.62m
EXASExact Sciences Corporation
0.34%67.8425.4%$159.30m
EXELExelixis, Inc.
-0.56%21.226.4%$135.63m
BMRNBioMarin Pharmaceutical Inc.
-1.03%101.814.4%$123.85m
AAgilent Technologies, Inc.
0.07%64.201.5%$122.71m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.